Reports of anxiety and depression rose to a significant 50% and 44%, respectively, among US residents during the first 9 months of the COVID-19 pandemic, according to study results published online in Translational Behavioral Medicine.
A history of depression may increase one’s perception of the amount of stress caused by the COVID-19 pandemic in their community, according to a study presented in a poster session at the ADAA 2021 Virtual Conference.
Confirming results from a previous smaller study, researchers found people who reported a history of childhood maltreatment had a more robust response to intravenous (IV) ketamine than other depressed adults seeking ketamine treatment.
Passive unobtrusive smartphone metadata could be used to prospectively predict elevations in mood disorder and depression symptoms, according to studies presented at the American Association for Geriatric Psychiatry 2021 Annual Meeting.
The use of psychedelics in psychotherapy can help patients go beyond ameliorating symptoms and confront their root causes of depression, Andrew D. Penn, RN, MS, NP, CNS, APRN-BC, and Charles Raison, MD, said at a session at the Psych Congress 2020…
Daily social media use is neither a strong nor consistent risk factor for depressive symptoms in adolescents in the United States, according to a new study published in the Journal of Adolescent Health.
Michael E. Thase, MD, spoke at the 2020 Psych Congress Elevate conference on adjunctive and combination therapies for difficult-to-treat depression. Here, he answers some of the questions asked by attendees.
Psych Congress cochair Charles Raison, MD, will give a virtual keynote speech August 20, 2020, for the University of Louisville Depression Center’s annual benefit. The event is free and open to the public.